Research
What adulterated means, and what it does not require
The federal drug law reaches the word adulterated on a list of named grounds. Half of them are written about devices, none of them requires anyone to have been harmed, and one of them turns on an answer given at a factory door.
A word the law deems rather than describes
The adulteration section does not describe a dirty drug. It opens by saying that a drug or device "shall be deemed to be adulterated" and then lists the grounds.
Deemed is the operative word here. Once any one ground is met, the article is adulterated as a matter of law, whether or not the word fits in ordinary speech.
Being adulterated is a state of an article rather than a finding about a person. What follows from that state lives in different sections of the same law, and this site covers those separately.
Five of the ten subsections are about devices
The section is titled "Adulterated drugs and devices" and its lettered subsections run from (a) to (j).
Subsections (e) through (i) are each written about a device, and each says so in its own operative clause. They cover devices that fall short of a performance standard, certain class III devices, banned devices, device manufacture, packing, storage or installation, and a device whose investigational-use exemption was not complied with.
The definitions section of the same law draws the boundary. A device is an article that "does not achieve its primary intended purposes through chemical action within or on the body of man or other animals". The same clause adds that it "is not dependent upon being metabolized for the achievement of its primary intended purposes".
An injectable peptide is on the other side of that sentence. Quoting one of those five subsections at it would be a real citation attached to a provision about something else.
Inside subsection (a) there are three more paragraphs that sit outside an ordinary human drug. Two are about a new animal drug and about animal feed containing one. The third is written for a compounded positron emission tomography drug.
The grounds about what is in the vial
Paragraph (a)(1) is the oldest and the shortest. A drug is adulterated "If it consists in whole or in part of any filthy, putrid, or decomposed substance".
Subsection (d) describes the failure this market actually worries about. A drug is adulterated if "any substance has been (1) mixed or packed therewith so as to reduce its quality or strength or (2) substituted wholly or in part therefor."
Read the two limbs apart, because they are not symmetrical. Mixing carries a qualifier, in that the mixing has to reduce quality or strength, while substitution carries no qualifier at all.
And note the phrase "wholly or in part". A vial holding some of the labeled peptide and some of something else is inside the paragraph.
Whether a given product on the open market is in that state is a different question, and it is one nothing on a product page can settle. This site treats counterfeit and grey-market supply as its own subject.
The ground about the container
Paragraph (a)(3) treats the container as part of the article rather than as packaging around it.
A drug is adulterated "if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health."
The verb is "may render", so nothing has to have leached into the solution and nobody has to have been harmed by it.
The manufacturing rules carry the working version of the same idea, and this site describes the container and closure requirement where the batch is being made.
The ground about the room
Paragraph (a)(2)(A) reaches conditions rather than contents.
A drug is adulterated if it "has been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health."
Once again the test is a possibility. The clause asks what the conditions made possible, not what a test later found.
The agency publishes its own list of what an inspector looks at in a compounding facility, and that list is walked through in this site's article on sterility and beyond-use dating rather than repeated here.
The two grounds that are about a claim
Two subsections attach to what a product says about itself rather than to what is inside it.
The first reaches a drug whose name is recognized in an official compendium, where its strength differs from, or its quality or purity falls below, the standard set out there.
The second reaches an article outside that paragraph, and it makes the seller's own statement the yardstick. It covers a drug "not subject to the provisions of paragraph (b) of this section". Such a drug is adulterated where "its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess".
Both are covered in full elsewhere on this site, in the article on what a compendial or pharmaceutical-grade claim commits a seller to. They are named here so the map is complete, not re-argued.
The ground that is about an answer at the door
Subsection (j) is the one almost nobody quotes, and it says nothing about the drug at all.
It opens "If it is a drug or device", so it reaches both. It then covers a drug that "has been manufactured, processed, packed, or held in any factory, warehouse, or establishment". Such a drug is adulterated where the owner, operator or agent of that establishment "delays, denies, or limits an inspection, or refuses to permit entry or inspection".
Four verbs appear, and two of them fall short of an outright refusal. Delaying an inspection is enough on its own, and so is limiting one.
Nothing about the contents changes, and the article reaches the adulterated state because of what somebody did at the door of the building it was held in.
Who may inspect what, and the narrow exception the law writes for pharmacies, is a separate question. This site answers it in the article on who oversees the pharmacy behind a vial.
What none of the grounds require
Read together, the list asks for less than most readers expect.
No ground requires that anyone was harmed. Two of them are written in terms of what "may" have happened rather than what did.
No ground requires a failed test result. The manufacturing ground turns on methods, facilities and controls, and the inspection ground turns on conduct.
No ground requires intent, a complaint or a report. Nothing has to be found by anyone before an article is in the state the section describes.
That is why the word appears so often and settles so little on its own. It is a doorway rather than a verdict.
What to do with the word when you meet it
When a page, a letter or a summary calls a product adulterated, the useful question is which ground.
A substitution claim and an inspection claim are both correct uses of the same word, and they say completely different things about a product.
The consequence is a further question again, in further sections, and this site covers what follows the conclusion in its own article.
Key takeaways
- Adulterated is a deeming word: meeting any one listed ground puts an article in that state as a matter of law.
- Five of the ten lettered subsections are written about devices, and a peptide sits outside all five.
- One subsection covers a substance mixed in or substituted wholly or in part for the drug, and substitution carries no qualifier.
- The container is part of the article, and the test is whether its material may render the contents injurious.
- Two grounds attach to the product's own claim about its strength, purity or quality rather than to its contents.
- A drug becomes adulterated where an inspection is delayed, denied or limited, with nothing about the drug changing.
- No ground requires harm, intent, a complaint or a failed test before the conclusion is reached.
Frequently asked questions
Does adulterated mean contaminated?
Not necessarily, because contamination is only one route among several that the section names. The section deems a drug adulterated on any of a list of grounds. They include a strength or purity below what the product claims, and a substance mixed in or substituted for the drug. They also include a container made of a poisonous or deleterious substance, methods and facilities that do not conform to current good manufacturing practice, and an inspection that was delayed, denied or limited. Only two of those grounds are about filth or unsanitary conditions.
Which parts of the adulteration section apply to an injectable peptide?
The section is titled "Adulterated drugs and devices" and five of its ten lettered subsections are written about devices, each saying so in its own operative clause. Those five cover performance standards, certain class III devices, banned devices, device manufacture and installation, and investigational-use device exemptions. Within the first subsection, two further paragraphs are animal-drug provisions and one is written for a compounded positron emission tomography drug. The rest reach an ordinary human drug.
Is a drug adulterated if the wrong substance is in the vial?
One subsection is written for exactly that. It deems a drug adulterated where any substance has been mixed or packed with it so as to reduce its quality or strength, or substituted wholly or in part for it. The two limbs are not the same. Mixing has to reduce quality or strength before it counts. Substitution carries no such qualifier, and the words "wholly or in part" mean a partial substitution is inside the paragraph.
Can a drug be adulterated when there is nothing wrong with it?
Yes, and the section says so in more than one place. One subsection turns on the methods, facilities and controls used to make the drug rather than on the drug itself. Another deems a drug adulterated where the owner or operator of the factory, warehouse or establishment holding it delays, denies or limits an inspection, or refuses to permit entry. In both cases the conclusion is reached without anyone opening the container.
Does anyone have to be harmed first?
No. Nothing in the section requires an injury, a complaint or a report. Two of the grounds are written around a possibility rather than an outcome. One covers a container made of a substance that "may render" the contents injurious to health. The other covers conditions under which a drug "may have been" contaminated with filth. The section describes a state an article is in, not damage anyone suffered.
What happens once a drug is adulterated?
That is a separate question in separate sections. Being adulterated is a state of an article. It becomes a violation when a person does one of a listed set of things with the article, and the law then names the proceedings that follow and the party allowed to bring them. This site covers that chain in the article on what happens after a drug is called misbranded, which walks the prohibited acts, the three court routes and the good-faith exceptions.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- Title 21 United States Code section 351, Adulterated drugs and devices, read in full including the deeming sentence, paragraphs (a)(1) through (a)(6), subsections (b) through (d), the five device subsections (e) through (i), and subsection (j) on delayed, denied or limited inspection — Office of the Law Revision Counsel, U.S. House of Representatives, September 2026
- Title 21 United States Code section 321, Definitions; generally, subsection (h) defining a device as an article that does not achieve its primary intended purposes through chemical action and is not dependent upon being metabolized, and subsection (g) defining a drug — Office of the Law Revision Counsel, U.S. House of Representatives, September 2026